SAN FRANCISCO--(BUSINESS WIRE)--Andersen Global expands its presence in Canada with the addition of collaborating firm Parlee McLaws LLP, adding complementary legal capabilities to its existing ...

Whether your team is a Stanley Cup contender and entering the NHL trading season as a buyer or a rebuilding club looking to sell, everybody has some sort of need at the trade deadline.

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

GLP-1 medications can significantly change how people experience hunger and satiety. For many, the reduction in constant food-related thoughts feels like a relief—sometimes the first quiet moment in ...

The city plans to begin issuing fines in June ranging from $50 to $200 to homeowners who don’t use official city bins for their trash. But thousands of people who ordered the bins still haven't ...

In this photo, Humana chief executive officer Jim Rechtin speaks at the Forbes Healthcare Summit December 4, 2025 at NYU Langone Health in New York in an appearance with the entrepreneur Mark Cuban on ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds within about 1½ years, a review of existing research has found. The paper also ...

Influencer Samantha Milton has lost 260 pounds with the help of GLP-1 — and she’s ready to share her story. Milton, who is known on social media as “Smaller Sam PCOS,” told People in a Monday, January ...

As with other prescription drugs, you’ll get the most out of it if you understand how it works and what to expect. Find out more about when and how to use semaglutide so it can improve your liver ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to a new KFF Health Tracking Poll. The poll also found that cost and side ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...